A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute ...

German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to interact ...

Bispecific antibodies, which bind simultaneously to two different antigens, can attack tumors via novel mechanisms of action that cannot be evoked with combinations of conventional monoclonal ...

In March 2025, AbViro LLC announced a phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare ...

TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...